Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Investor Growth Capital on the investment in Memira Holding AB
Mandate

Vinge advises Investor Growth Capital on the investment in Memira Holding AB

October 02, 2007

Vinge advises Investor Growth Capital in connection with the investment in Memira Holding AB, a Scandinavian laser eye surgery chain. Memira’s surgeries treat short and long sightedness as well as astigmatism, which is a common refractive error. The investment in the company will make Investor Growth Capital the owner of 40 per cent of the shares.

Investor Growth Capital is represented by partner Johan Winnerblad assisted by associates Johan Larsson, Tom Zachrisson and Theresa Kovac.

Related

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

 Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026

Vinge advises Studentbostäder i Norden AB (publ) in connection with its issuance of bonds in an amount of SEK 500 million and its early redemption of outstanding bonds

 Vinge has advised Studentbostäder i Norden AB (publ) in connection with its issuance of senior unsecured bonds in an amount of SEK 500 million (within a framework of SEK 750 million) and in parallel with the company's voluntary early redemption of previously issued bonds.
March 12, 2026

Vinge has advised Skeptiva AB in connection with its financing round

 Skeptiva is developing the next generation of cybersecurity defenses against fraud. The company has developed an AI application that detects attacks and alerts users in real time.
March 11, 2026